Presenting companies announced for 2019 Rocky Mountain Life Science Conference Sept. 4-5

Friday July 26, 2019 0 comments Tags: Denver, Rocky Mountain Life Science Investor Conference, CBSA, Jennifer Jones Paton

DENVER -- Colorado BioScience Association  announced more than two dozen companies chosen by a panel of investors to present at the 2019 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), including 21 From Colorado.rocky-mountain-inveswtor-conference-logo-2019

Leading life science innovators from the Rocky Mountain region will pitch to investors and strategic partners during the event to be held Sept. 4-5 in Vail.

The 7th Biennial Rocky Mountain Life Science Investor and Partnering Conference brings together leading investors, senior executives, and top life science innovators to cultivate partnerships in the dynamic Rocky Mountain region and discuss the future of health innovation.

The conference allows investors to evaluate fresh opportunities and offers networking opportunities for attendees in a collaborative, informal environment.

Companies chosen to pitch to a select group of corporate leaders, strategic partners and investors from major U.S. financial hubs include early and mid-stage companies doing groundbreaking work to save and improve lives in medical device, diagnostic, biotech, pharma and digital health.

“Supporting access to capital for companies at all stages of commercialization is a top priority for CBSA and the reason we lead the Rocky Mountain Life Science Investor and Partnering Conference,” said Jennifer Jones-Paton, CBSA president and CEO.

“We’re pleased to introduce a dynamic group of companies representing the future of life-saving health innovation to investors from major financial hubs.”




Colorado companies set to present include: (Boulder) Accure, Aktivax, Aspero Medical, Biodesix, Brava Diagnostics, MFB Fertility, OnKure Therapeutics, Orbit Genomes, Sinfonia BioTherapeutics, Solo-Dex; (Denver) Agathos, ClinOne Inc., Health Sqyre, IMIDEX, ImmunoMolecular Therapeutics; (Highlands Ranch) Securisyn Medical; (Westminster) Health Scholars; (Lafayette) Neuraptive Therapeutics; (Louisville) AmideBio;(Fort Collins) PhotonPharma; (Longmont) KromaTiD.



Presenting companies and investors will hear from Johnson & Johnson’s Global Strategy and Digital Innovation Leader Dr. Emmanuel Fombu on the convergence of digital technologies and healthcare during a breakfast keynote, and will learn about the emergence of health systems investment to Accelerate Innovation with panelists Dr. Garrett Vygantas of OSF Ventures, Dan Galles of Providence Ventures and Kimberly Muller of CU Healthcare Innovation during a lunchtime panel discussion.

The 2019 Rocky Mountain Life Science Investor & Partnering Conference, led by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah, will kick off with a cocktail networking reception at the Vail Marriott Mountain Resort on Sept. 4, followed by the full-day conference with company presentations on Sept. 5.